Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Deloitte
McKesson
US Army
Queensland Health
Mallinckrodt
Julphar
Cipla
Chubb

Generated: January 16, 2019

DrugPatentWatch Database Preview

Aurobindo Company Profile

« Back to Dashboard

What is the competitive landscape for AUROBINDO, and what generic and branded alternatives to AUROBINDO drugs are available?

AUROBINDO has three hundred and fifty-five approved drugs.

There are thirty-five tentative approvals on AUROBINDO drugs.

Drugs and US Patents for Aurobindo

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride SYRUP;ORAL 090750-001 Feb 2, 2010 OTC No No ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride TABLET;ORAL 090760-004 Aug 5, 2015 OTC No No ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd ERTAPENEM SODIUM ertapenem sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 209133-001 Jun 25, 2018 AP RX No No ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd ARGATROBAN IN SODIUM CHLORIDE argatroban SOLUTION;INTRAVENOUS 209552-001 Nov 27, 2018 RX No No ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd ALPRAZOLAM alprazolam TABLET;ORAL 203346-002 Jul 31, 2015 AB RX No No ➤ Sign Up ➤ Sign Up
Aurobindo Pharma LAMOTRIGINE lamotrigine TABLET;ORAL 078956-001 Jan 27, 2009 AB RX No No ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd LEVETIRACETAM IN SODIUM CHLORIDE levetiracetam INJECTABLE;IV (INFUSION) 207160-003 Jan 4, 2017 AP RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for AUROBINDO drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Baxter
Accenture
Boehringer Ingelheim
Fish and Richardson
Merck
US Department of Justice
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.